2023. Assessment of YME1L and mitofusin2 as a possible diagnostic and/or therapeutic target in hepatocellular carcinoma. Indian Journal of Biochemistry and Biophysics (IJBB). 60, 1 (Jun. 2023), 43–54. DOI:https://doi.org/10.56042/ijbb.v60i1.62503.